These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29268059)

  • 21. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of omega-3 fatty acid supplementation in patients with Alzheimer disease: A systematic review and meta-analysis.
    Araya-Quintanilla F; Gutiérrez-Espinoza H; Sánchez-Montoya U; Muñoz-Yañez MJ; Baeza-Vergara A; Petersen-Yanjarí M; Fernández-Lecaros L
    Neurologia (Engl Ed); 2020 Mar; 35(2):105-114. PubMed ID: 28986068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of nutritional supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials.
    Molina-Leyva I; Molina-Leyva A; Bueno-Cavanillas A
    Acta Ophthalmol; 2017 Dec; 95(8):e677-e685. PubMed ID: 28371493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review and meta-analysis of omega-3-fatty acids in elderly patients with depression.
    Bae JH; Kim G
    Nutr Res; 2018 Feb; 50():1-9. PubMed ID: 29540267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the evidence for dietary interventions in preventing or slowing the progression of age-related macular degeneration.
    Evans JR; Lawrenson JG
    Ophthalmic Physiol Opt; 2014 Jul; 34(4):390-6. PubMed ID: 24903538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
    Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of ω-3 fatty acid supplementation in parenteral nutrition on the outcome of patients with sepsis: a systematic review and meta-analysis].
    Mo Y; Hu X; Chang L; Ma P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):142-7. PubMed ID: 24598286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
    Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of omega-3 polyunsaturated fatty acids in cardiovascular health.
    Barrett SJ
    Altern Ther Health Med; 2013; 19 Suppl 1():26-30. PubMed ID: 23981464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhoea pain: Systematic literature review and meta-analysis.
    Snipe RMJ; Brelis B; Kappas C; Young JK; Eishold L; Chui JM; Vatvani MD; Nigro GMD; Hamilton DL; Convit L; Carr A; Condo D
    Nutr Diet; 2024 Feb; 81(1):94-106. PubMed ID: 37545015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials.
    Avallone R; Vitale G; Bertolotti M
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment of Attention-Deficit/Hyperactivity Disorders with polyunsaturated fatty acids - an effective treatment alternative?].
    Frölich J; Döpfner M
    Z Kinder Jugendpsychiatr Psychother; 2008 Mar; 36(2):109-16. PubMed ID: 18622940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 fatty acids and pregnancy: current implications for practice.
    Mozurkewich EL; Klemens C
    Curr Opin Obstet Gynecol; 2012 Mar; 24(2):72-7. PubMed ID: 22327736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of omega-3 fatty acids on cognitive function in aging and dementia: a systematic review.
    Issa AM; Mojica WA; Morton SC; Traina S; Newberry SJ; Hilton LG; Garland RH; Maclean CH
    Dement Geriatr Cogn Disord; 2006; 21(2):88-96. PubMed ID: 16340205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials with multiple endpoints can establish a correlation, but not (yet) causality, between dietary supplementation with omega-3 fatty acids and keratoconjunctivitis sicca.
    Mendoza RL
    J Med Econ; 2018 Aug; 21(8):733-744. PubMed ID: 29781353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
    Freund-Levi Y; Basun H; Cederholm T; Faxén-Irving G; Garlind A; Grut M; Vedin I; Palmblad J; Wahlund LO; Eriksdotter-Jönhagen M
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):161-9. PubMed ID: 17582225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PUFA for prevention and treatment of dementia?
    Carrié I; Abellan Van Kan G; Rolland Y; Gillette-Guyonnet S; Vellas B
    Curr Pharm Des; 2009; 15(36):4173-85. PubMed ID: 20041819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intake of ω-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A systematic review and meta-analysis.
    Gioxari A; Kaliora AC; Marantidou F; Panagiotakos DP
    Nutrition; 2018 Jan; 45():114-124.e4. PubMed ID: 28965775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease.
    Fassett RG; Gobe GC; Peake JM; Coombes JS
    Am J Kidney Dis; 2010 Oct; 56(4):728-42. PubMed ID: 20493605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.